A phase III, single-arm, 6-month trial of a wide-dose range oral testosterone undecanoate product.

Published in: Therapeutic advances in urology (2024)

URL: https://clinicaltrials.gov/ unique identifier NCT04467697, conducted under NCT03198728. Post-completion, clinicaltrials.gov requested creation of the separate NCT04467697 identifier. All subjects were recruited under NCT03198728.

Keyphrases

phase iii
open label
clinical trial
phase ii
double blind
placebo controlled
study protocol
replacement therapy